| Indicators | Browse All

Gelteq Limited (GELS)

Healthcare | Drug Manufacturers - Specialty & Generic | Clayton, Australia | NasdaqCM
0.54 USD +0.02 (3.748%) ⇧ (July 13, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 5:31 a.m. EDT

The immediate outlook is severely bearish as the stock has lost nearly 40% of its value over the last two months, trading well below both its 50-day and 200-day moving averages. This technical breakdown coincides with a catastrophic collapse in the company's financial health: the firm is burning cash aggressively with negative operating and free cash flows, while carrying a debt load that dwarfs its meager cash reserves. The balance sheet is critically impaired, evidenced by a current ratio of just 0.09, indicating severe liquidity distress. Although the company recently secured some financing and showed promise in preclinical trials, the market has already punished the stock heavily, and the lack of any dividend history combined with deteriorating fundamentals suggests a high-risk speculative play rather than an investment opportunity.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.319844
MSTL0.329191
AutoARIMA0.329678
AutoETS0.329695

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 22%
H-stat 3.60
Ljung-Box p 0.000
Jarque-Bera p 0.008
Excess Kurtosis 0.38
Attribute Value
Sector Healthcare
Debt to Equity Ratio 36.01
Revenue per Share 0.046
Market Cap 5,781,829
Website https://www.gelteq.com

Info Dump

Attribute Value
52 Week Change -0.68786126
Address1 Monash Innovation Labs
Address2 G.60, 22 Alliance Lane
All Time High 5.5
All Time Low 0.387
Ask 0.6532
Ask Size 2
Average Daily Volume10 Day 68,160
Average Daily Volume3 Month 3,760,209
Average Volume 3,760,209
Average Volume10Days 68,160
Bid 0.3794
Bid Size 2
Book Value 0.880491
City Clayton
Country Australia
Crypto Tradeable 0
Currency USD
Current Price 0.5398
Current Ratio 0.091
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 0.55
Day Low 0.5
Debt To Equity 36.01
Display Name Gelteq
Ebitda -5,137,130
Ebitda Margins 0.0
Enterprise To Ebitda -2.169
Enterprise To Revenue 23.615
Enterprise Value 11,141,563
Eps Trailing Twelve Months -0.5
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.60824
Fifty Day Average Change -0.06844002
Fifty Day Average Change Percent -0.1125214
Fifty Two Week Change Percent -68.786125
Fifty Two Week High 2.02
Fifty Two Week High Change -1.4802
Fifty Two Week High Change Percent -0.7327723
Fifty Two Week Low 0.387
Fifty Two Week Low Change 0.1528
Fifty Two Week Low Change Percent 0.39483204
Fifty Two Week Range 0.387 - 2.02
Financial Currency AUD
First Trade Date Milliseconds 1,730,208,600,000
Float Shares 5,150,874
Free Cashflow -4,751,912
Full Exchange Name NasdaqCM
Full Time Employees 7
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.75541
Gross Profits 356,402
Has Pre Post Market Data 1
Held Percent Insiders 0.47527
Held Percent Institutions 0.00582
Implied Shares Outstanding 10,711,059
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Ipo Expected Date 2,024-10-29
Language en-US
Last Fiscal Year End 1,751,241,600
Long Business Summary Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Long Name Gelteq Limited
Market us_market
Market Cap 5,781,829
Market State PRE
Max Age 86,400
Message Board Id finmb_1779819906
Most Recent Quarter 1,767,139,200
Net Income To Common -7,083,198
Next Fiscal Year End 1,782,777,600
Non Diluted Market Cap 5,507,626
Open 0.55
Operating Cashflow -3,009,640
Operating Margins -19.852829
Payout Ratio 0.0
Phone 61 3 9087 3990
Pre Market Change 0.0013999939
Pre Market Change Percent 0.2593542
Pre Market Price 0.5412
Pre Market Time 1,784,025,690
Previous Close 0.5203
Price Hint 4
Price To Book 0.61306703
Price To Sales Trailing12 Months 12.254856
Profit Margins 0.0
Quick Ratio 0.072
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0195
Regular Market Change Percent 3.74784
Regular Market Day High 0.55
Regular Market Day Low 0.5
Regular Market Day Range 0.5 - 0.55
Regular Market Open 0.55
Regular Market Previous Close 0.5203
Regular Market Price 0.5398
Regular Market Time 1,783,972,801
Regular Market Volume 28,477
Return On Assets -0.17613001
Return On Equity -0.42933998
Revenue Growth 0.489
Revenue Per Share 0.046
Sand P52 Week Change 0.20365608
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 10,711,059
Shares Percent Shares Out 0.0156
Shares Short 167,463
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 77,097
Short Name Gelteq Limited
Short Percent Of Float 0.023599999
Short Ratio 0.02
Source Interval 15
State VIC
Symbol GELS
Total Cash 9,349
Total Cash Per Share 0.001
Total Debt 5,113,954
Total Revenue 471,799
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.5
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 0.85973
Two Hundred Day Average Change -0.31993002
Two Hundred Day Average Change Percent -0.3721285
Type Disp Equity
Volume 28,477
Website https://www.gelteq.com
Zip 3,800